The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 2,242 | 1,984 | 3,497 | 2,606 |
| Origination of loans for sale | 9,407 | 11,599 | 11,135 | 18,141 |
| Sale of loans originated for sale | 10,779 | 13,487 | 9,610 | 19,178 |
| Depreciation and amortization, net of accretion | 1,325 | 1,507 | 1,453 | 3,231 |
| Deferred tax expense (benefit) | - | -556 | - | - |
| Stock based compensation expense | 126 | 102 | 116 | 229 |
| (gain) loss on sale of property and equipment | - | -55 | - | - |
| Cash payments for lease liabilities | 404 | 402 | 401 | 800 |
| (gain) loss on sale of foreclosed real estate | - | 0 | 0 | 0 |
| (gain) loss on sale of securities, net | - | -1,577 | 0 | 0 |
| (gain) loss on sale of real estate | - | - | -56 | 0 |
| (gain) loss on tax credit investment | - | 90 | - | - |
| (gain) loss on sale of loans held-for-sale, net | 276 | 346 | 282 | 624 |
| (increase) decrease of cash value of bank owned life insurance | 201 | 207 | 210 | 418 |
| (gain) loss on death benefits of bank-owned life insurance | - | 308 | 236 | - |
| (gain) loss on derivatives | -19 | 0 | -17 | -16 |
| Provision for (benefit from) credit losses | 55 | -84 | -301 | 180 |
| Interest receivable | -81 | 196 | -66 | -70 |
| Interest payable | 13 | 205 | -508 | -34 |
| Other assets | -1,145 | -870 | -419 | -2,136 |
| Accrued expenses and other liabilities | -1,862 | 1,798 | -961 | -6,669 |
| Total adjustments | 1,393 | 5,757 | -2,297 | -1,646 |
| Proceeds from sales of securities available-for-sale | - | 24,519 | 0 | 0 |
| Net cash provided by (used in) operating activities | 3,635 | 7,741 | 1,200 | 960 |
| Proceeds from maturities and pay downs of securities available-for-sale | 2,886 | 2,497 | 3,247 | 5,687 |
| Purchase of loans | 10,312 | - | - | - |
| Net change in loans receivable | -5,402 | -22,948 | -10,113 | -24,593 |
| Purchase of premises and equipment | 135 | 240 | 152 | 461 |
| Proceeds from sale of premises and equipment | - | 152 | 667 | 0 |
| Proceeds from sale of foreclosed real estate | 0 | 0 | -72 | 72 |
| Proceeds from death benefits of bank owned life insurance | - | 772 | 535 | - |
| Net cash provided by (used in) investing activities | -2,159 | 50,648 | 14,338 | 29,891 |
| Change in deposits | -7,900 | -23,675 | -4,204 | -5,716 |
| Proceeds from borrowed funds | 15,000 | 10,000 | -10,000 | 40,000 |
| Repayment of borrowed funds | 10,000 | 20,000 | 0 | 40,000 |
| Net surrender value of restricted stock awards | 60 | 4 | 146 | 0 |
| Change in repurchase agreements | - | - | 95 | 8,215 |
| Change in federal funds purchased and repurchase agreements | 1,112 | -413 | - | - |
| Dividends paid | 520 | 518 | 519 | 520 |
| Net cash provided by (used in) financing activities | -2,368 | -42,920 | -14,774 | 1,979 |
| Net change in cash and cash equivalents | -892 | 15,469 | 764 | 32,830 |
| Cash and cash equivalents at beginning of period | 119,647 | 104,178 | 70,584 | - |
| Cash and cash equivalents at end of period | 118,755 | 119,647 | 104,178 | - |
Finward Bancorp (FNWD)
Finward Bancorp (FNWD)